Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Oncology

• Publication date

  2016-09-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2016.66.6198PMID 27480145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2017cited by this paper
• A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.

  2016cited by this paper
• Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer

  2015cited by this paper
• Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

  2015cited by this paper
• Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

  2015cited by this paper
• Rectal Cancer, Version 2.2015.

  2015cited by this paper
• Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines

  2015cited by this paper
• Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.

  2014cited by this paper
• Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer

  2014cited by this paper
• Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Disease-free survival results at interim analysis.

  2014cited by this paper
• Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.

  2014cited by this paper
• Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial.

  2013cited by this paper
• Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

  2013cited by this paper
• Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2013cited by this paper
• Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

  2012cited by this paper
• Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.

  2011cited by this paper
• Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

  2011cited by this paper
• Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer.

  2010cited by this paper
• Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

  2010cited by this paper
• Late side effects and quality of life after radiotherapy for rectal cancer.

  2010cited by this paper
• Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

  2010cited by this paper
• Risk factors for faecal incontinence after rectal cancer treatment

  2007cited by this paper
• Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.

  2005cited by this paper
• Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

  2005cited by this paper
• Randomization and Blinding

  2005cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER

  2001cited by this paper
• Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients.

  1999cited by this paper

• Randomized Parallel-Group Phase II Study (NEOTERIC) of Atezolizumab With or Without Tiragolumab After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

  2026cites this paper
• Efficacy comparison of preoperative versus postoperative radiotherapy for rectal cancer: an analysis based on the SEER database.

  2026cites this paper
• Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer

  2026cites this paper
• Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial

  2026cites this paper
• Comparative safety and short-term outcomes of intraoperative radiotherapy versus neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a retrospective study

  2026cites this paper
• Survival benefit from evidence-based treatment for rectal cancer among older people - Analysis of SEER-medicare.

  2026cites this paper
• Contemporary neoadjuvant strategies for rectal cancer: The GRECCAR snapshot study

  2026influential citation
• Associations of pretreatment emotional distress with adherence to therapy for patients with locally advanced rectal cancer: a post hoc analysis of the Chinese FOWARC phase 3 randomized clinical trial

  2025influential citation
• Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis

  2025cites this paper
• Lessons from FOWARC: moving towards the more precise use of radiation therapy in the era of total neoadjuvant therapy

  2025cites this paper
• Evaluation of the effectiveness of using capecitabine versus capecitabine combined with oxaliplatin during preoperative radiotherapy for patients with rectal cancer: A retrospective cohort study

  2025cites this paper
• Impact of Subcutaneous Adipose Tissue Index Change During Neoadjuvant Chemoradiotherapy on Disease-Free Survival and Tumor Response in Patients with Locally Advanced Rectal Cancer

  2025cites this paper
• Pathologic Complete Response and Survival in Rectal Cancer

  2025cites this paper
• “Add More Arrows to Your Quiver”: The Role of Adding Another Chemotherapy Drug to Fluoropyrimidine and Long Term Radiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis

  2025cites this paper
• Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial

  2025cites this paper
• Neoadjuvant Treatment for Locally Advanced Rectal Cancer: Current Status and Future Directions

  2025cites this paper
• The Landmark Series: Neoadjuvant Therapy for Locally Advanced Rectal Cancer

  2025cites this paper
• Network meta-analysis of RTCs for efficacy of neoadjuvant treatment in rectal cancer.

  2025cites this paper
• Neoadjuvant chemotherapy versus long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of 5,168 cases

  2025cites this paper
• Transanal total mesorectal excision for locally advanced rectal cancer following neoadjuvant chemoradiotherapy

  2025cites this paper
• Comparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials

  2025influential citation
• Synergistic Effect of Photodynamic Therapy with Multimodal Therapy Achieves Anus Preservation in MSS Ultra-low Rectal Cancer-A Case Report and Literature Review.

  2025cites this paper
• Neoadjuvant combination immunotherapy for colorectal cancer: clinical and molecular predictors of pathological complete response and safety assessment

  2025cites this paper
• Neoadjuvant FOLFOXIRI for locally advanced rectal cancer: A retrospective analysis focusing on long-term anal preservation.

  2025cites this paper
• Transcatheter rectal arterial chemoembolization with oxaliplatin and concurrent chemoradiotherapy in patients with locally advanced rectal cancer: A retrospective comparative study.

  2025cites this paper
• Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer.

  2025cites this paper
• Compliance and Toxicity of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis

  2025cites this paper
• Neoadjuvant Chemotherapy Without Radiation for Locally Advanced Rectal Cancer: A Meta-analysis of Surgical Outcomes after Total Mesorectal Excision.

  2025cites this paper
• Controversies and Perspectives in the Current Management of Patients with Locally Advanced Rectal Cancer—A Systematic Review

  2025cites this paper
• Efficacy and safety of neoadjuvant chemoradiotherapy versus chemotherapy alone in locally advanced rectal cancer

  2025influential citation
• Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients

  2025cites this paper
• Nodal Downstaging in Rectal Cancer Patients: Survival is Promising if YpN0 is Achieved.

  2025cites this paper
• Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not?

  2025cites this paper
• Rethinking the impact of radiation dosing on neoadjuvant chemoradiotherapy efficacy and organ preservation in locally advanced rectal cancer.

  2025cites this paper
• Reply to: Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not?

  2025cites this paper
• Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer

  2025cites this paper
• Neoadjuvant FOLFOXIRI plus bevacizumab without radiotherapy for high-risk rectal cancer: multicentre phase II trial

  2025influential citation
• Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Locally Advanced Rectal Cancer: A Multicenter Propensity Score-Matched Study.

  2025cites this paper
• Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy

  2024cites this paper
• Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC) for Non-Operative Management (NOM) for Rectal Adenocarcinoma: Systematic Review and Guidelines.

  2024cites this paper
• Short‐Course TNT Improves Rectal Tumor Downstaging in a Retrospective Study of the US Rectal Cancer Consortium

  2024cites this paper
• Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancer.

  2024cites this paper
• Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial

  2024cites this paper
• Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years

  2024cites this paper
• Retrospective Analysis of Therapeutic Efficacy and Prognosis of Neoadjuvant Chemotherapy in Patients With Mid to Low Locally Advanced Rectal Cancer.

  2024cites this paper
• The impact of radiation dose on chemoradiation outcomes and rectum preservation in locally advanced rectal cancer: A retrospective study.

  2024cites this paper
• Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis

  2024cites this paper
• Could elective nodal irradiation for locally advanced rectal cancer be omitted in the context of total neoadjuvant therapy? An analysis of the recurrence sites of rectal cancer

  2024cites this paper
• Modified FOLFOX6 with Cetuximab versus with Radiotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: A Single-Center, Prospective, Randomized Controlled Trial.

  2024cites this paper
• The Influence of Pelvic Bone Dose-volume Parameters on Bone Marrow Suppression During Radiation Therapy in Patients With Stage I to III Rectal Cancer Based on Real-world Data

  2024cites this paper
• Pathological response following neoadjuvant immunotherapy and imaging characteristics in dMMR/MSI-H locally advanced colorectal cancer

  2024cites this paper
• NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.

  2024cites this paper
• Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused Update.

  2024cites this paper
• Neoadjuvant chemotherapy with capecitabine combined with oxaliplatin for mid-low locally advanced rectal cancer with negative mesorectal fascia: Long-term outcomes of a prospective trial (PKUCH-R03 trial).

  2024cites this paper
• Neoadjuvant Treatment in Rectal Cancer

  2024cites this paper
• Oncological Outcomes and Response Rate After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Network Meta-Analysis Comparing Induction vs. Consolidation Chemotherapy vs. Standard Chemoradiation.

  2024cites this paper
• Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?

  2024cites this paper
• The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review

  2024cites this paper
• Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation

  2024cites this paper
• Vasorin (VASN) overexpression promotes pulmonary metastasis and resistance to adjuvant chemotherapy in patients with locally advanced rectal cancer

  2024cites this paper
• Neoadjuvant treatment of colorectal cancer: comprehensive review

  2024cites this paper
• Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial

  2024cites this paper
• Anti‐angiogenesis in colorectal cancer therapy

  2024cites this paper
• Recent advances in rectal cancer treatment – are we on the right track?

  2024cites this paper
• Role of Oxaliplatin in the Neoadjuvant Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: a Review of Evidence

  2024cites this paper
• Primary surgery followed by selective chemoradiotherapy versus preoperative chemoradiotherapy followed by surgery for locally advanced rectal cancer: A Randomized Clinical Trial.

  2024cites this paper
• Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer

  2024cites this paper
• Efficacy and Safety of Preoperative Transcatheter Rectal Arterial Chemoembolisation in Patients with Locally Advanced Rectal Cancer: Results from a Prospective, Phase II PCAR Trial.

  2024cites this paper
• Long-term Changes in Low Anterior Resection Syndrome in Survivors of Rectal Cancer: Longitudinal Follow-up of a Randomized Controlled Trial

  2024cites this paper
• Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: pioneering, standardization, challenges and personalization.

  2024cites this paper
• Omission of Radiotherapy for Locally Advanced Rectal Cancer: A Step Toward Patient-Centric Treatment Decision-Making

  2024cites this paper
• Radiomics prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

  2024cites this paper
• Fibrosis signature of anastomotic margins for predicting anastomotic stenosis in rectal cancer with neoadjuvant chemoradiotherapy and sphincter-preserving surgery

  2024cites this paper
• GRECCAR 14 – a multicentric, randomized, phase II–III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol

  2023cites this paper
• Short‐course radiation with consolidation chemotherapy does not increase operative morbidity compared to long‐course chemoradiation: A retrospective study of the US rectal cancer consortium

  2023cites this paper
• Immune checkpoint status and oncogenic mutation profiling of rectal cancer after neoadjuvant chemotherapy (KSCC1301‐A2)

  2023cites this paper
• Total neoadjuvant therapy for rectal cancer: evidence and challenge

  2023cites this paper
• Neoadjuvant chemotherapy (CAPOX) alone for low- and intermediate-risk stage II/III rectal cancer: Long-term follow-up of a prospective single-arm study.

  2023cites this paper
• The unique role of cuproptosis in the prognosis and treatment of rectum adenocarcinoma

  2023cites this paper
• Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial

  2023cites this paper
• Toxicity, Disease Control, and Survival Outcomes of Intensified Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Single-Institution Study

  2023cites this paper
• Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial

  2023cites this paper
• Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study

  2023cites this paper
• Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial

  2023cites this paper
• Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy

  2023cites this paper
• Adjuvant Radiotherapy Is Not Necessary for Stage III Mucinous Rectal Cancer: Evidence Based on Long Survival Analysis from SEER Data

  2023cites this paper
• Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

  2023influential citation
• Automatic treatment outcome prediction with DeepInteg based on multimodal radiological images in rectal cancer

  2023cites this paper
• Accurate tumor segmentation and treatment outcome prediction with DeepTOP.

  2023cites this paper
• Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial

  2023cites this paper
• A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.

  2023cites this paper
• Do treated rectal tumors appear differently on MRI after chemotherapy versus chemoradiotherapy?

  2023cites this paper
• Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?

  2023cites this paper
• Texture analysis of apparent diffusion coefficient maps: can it identify nonresponse to neoadjuvant chemotherapy for additional radiation therapy in rectal cancer patients?

  2023cites this paper
• Quality of Surgical Outcome Reporting in Randomised Clinical Trials of Multimodal Rectal Cancer Treatment: A Systematic Review

  2023cites this paper
• mFOLFOX4 with or without radiation in neoadjuvant treatment of locally advanced middle and low rectal cancer

  2022cites this paper
• Strategies to Optimize Treatment for Locally Advanced Rectal Cancer

  2022cites this paper
• Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer

  2022cites this paper
• Retrospective Evaluation of the Impact of Dose Escalation Using Pre-operative Simultaneous Integrated Boost Volumetric Modulated Arc Therapy on the Outcome of Locally Advanced Rectal Cancer Patients

  2022cites this paper
• Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial

  2022cites this paper